On Thursday, Health Canada approved the drug tislelizumab, sold under the brand name Tevimbra, to be used in combination with two other chemotherapy drugs.
Health Canada approves new throat cancer treatment
Published 2 hours ago
Source: globalnews.ca
Categories
HealthCancertevimbra
Related Articles from globalnews.ca
35 minutes ago
Academic whose report led to fracking ban questions N.S. government’s gas claims
43 minutes ago
Quebec paramedics, ambulance technicians to strike Dec. 24 but keep essential service
45 minutes ago
Highways closed, BC Ferries busy as holiday travel season continues
49 minutes ago
Toronto transit ridership sputters, failing to hit projections or 2024 totals
1 hour ago
Pulled ’60 Minutes’ segment surfaces on web with Canadian broadcaster’s branding
1 hour ago